-+ 0.00%
-+ 0.00%
-+ 0.00%

Moderna Publishes Analyst Day Transcript

PUBT·11/19/2026 21:53:21
Listen to the news
Moderna Publishes Analyst Day Transcript
  • Moderna's November 12, 2026, Analyst Day featured CEO Stephane Bancel, CFO James Mock and other executives, with analysts attending.
  • Management expects investment of about $4 billion in 2027, versus $3.8 billion in 2026, primarily reflecting increased spending on intismeran.
  • Annual investment is subsequently projected at $4 billion-$4.5 billion, with additional spending dependent on pipeline results.
  • Intismeran could launch in 2027, subject to regulatory approval; the commercial manufacturing site is targeting approximately six weeks from sample collection to dosing.
  • Mock cautioned against assuming recurring vaccine revenue growth of 15%-25%, the current 2026 forecast, despite expectations for further expansion.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Moderna Inc. published the original content used to generate this news brief on November 19, 2026, and is solely responsible for the information contained therein.